Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.97
+0.02 (0.29%)
At close: Nov 3, 2026, 4:00 PM EST
6.75
-0.22 (-3.16%)
After-hours: Nov 3, 2026, 4:10 PM EST
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $192.38 million as of November 3, 2026. It is the 20,786th most valuable company in the world and the 3,598th biggest in the United States. Its market cap has increased by 100.02% in one year.
Market Cap
192.38M
Enterprise Value
132.93M
1-Year Change
100.02%
Global Rank
Country Rank
#3,598 United States
Category
ChartMarket Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $192.38M, a decrease of -77.50%. That is a compound annual growth rate of -17.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 192.38M | 92.12% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 208.68M |
| Artiva Biotherapeutics | 204.85M |
| Palisade Bio | 202.15M |
| Cartesian Therapeutics | 196.36M |
| ProQR Therapeutics | 196.16M |
| Alpha Cognition | 190.34M |
| Compugen | 187.55M |
| Upstream Bio | 186.77M |